MDXHealth
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
29 may 2008 - 08:23
Statutory name
MDXHealth
Title
OncoMethylome’s Novel Test for Bladder Cancer Demonstrates Excellent Performance in Clinical Trial
Comments
Liege (Belgium) – May 29, 2008, 08:00 CET – OncoMethylome Sciences (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) released additional data today from an ongoing clinical verification trial of their bladder cancer test.
- The new data confirms the ability of this non-invasive urine-based test to accurately detect early-stage bladder cancer
- The test procedure was successfully simplified without compromising performance
- Multi-center trial shows that the test is highly reproducible
Related downloads
Date last update: 16 July 2025